Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers. (2022)

First Author: Anderson EL
Attributed to:  Physiological resilience: mechanisms and consequences funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-05225-8

PubMed Identifier: 35058547

Publication URI: http://europepmc.org/abstract/MED/35058547

Type: Journal Article/Review

Volume: 12

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322